Clinical trials
Carcinoma, Squamous Cell trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Terminated | 8 |
| Unknown status | 5 |
| Recruiting | 4 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 5 |
| University Hospital, Ghent | 3 |
| Boehringer Ingelheim | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Centre Hospitalier Universitaire UCLouvain Namur | 1 |
| Clinuvel Pharmaceuticals Limited | 1 |
| Daiichi Sankyo | 1 |
| Genmab | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Squamous Cell | 31 |
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Head and Neck Neoplasms | 8 |
| Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Laryngeal Diseases | 3 |
| Neoplasm Metastasis | 3 |
| Recurrence | 3 |
| Adenocarcinoma | 2 |
| Anus Neoplasms | 2 |
Trials
Showing 26 to 31 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.